ANTHEM BIOSCIENCES LTD (ANTHEM) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in 2006, Anthem BiosciencesLtd is in the business of providing CRDMO services and the manufacture and sale of specialty ingredients.[1]

ANTHEMUpdated 30 Aug 2026, 22:19

Anthem Biosciences Ltd

Market Cap

₹50,695Cr.

Current Price

₹900

High / Low

₹943/579

Stock P/E

78.9

ROE24.3%
ROCE32.0%
Book Value₹56.7
Face Value₹2.00
Dividend Yield0.22%

About

Incorporated in 2006, Anthem BiosciencesLtd is in the business of providing CRDMO services and the manufacture and sale of specialty ingredients.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days686184979512689100
Inventory Days123186295213912916755
Days Payable7287505877615432
Cash Conversion Cycle1191606391157194201122
Working Capital Days2220277511412912882
ROCE %26%55%51%28%25%31%32%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 30 August 2026 at 22:19


Designed & Shipped by Harshit Bansal